Bayesian Capital Management’s iRhythm Holdings IRTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,386
Closed -$754K 329
2025
Q3
$754K Buy
+4,386
New +$697K 0.15% 206
2023
Q4
Sell
-4,287
Closed -$404K 885
2023
Q3
$404K Buy
+4,287
New +$436K 0.05% 413
2022
Q4
Sell
-2,600
Closed -$326K 896
2022
Q3
$326K Buy
+2,600
New +$375K 0.07% 390
2019
Q3
Sell
-3,566
Closed -$282K 597
2019
Q2
$282K Buy
3,566
+400
+13% +$29.1K 0.06% 372
2019
Q1
$237K Sell
3,166
-2,200
-41% -$188K 0.05% 439
2018
Q4
$373K Sell
5,366
-6,510
-55% -$494K 0.08% 350
2018
Q3
$1.12M Buy
+11,876
New +$1.03M 0.18% 152
2017
Q4
Sell
-5,734
Closed -$297K 630
2017
Q3
$297K Buy
+5,734
New +$260K 0.07% 366

Other funds holding IRTC

Bayesian Capital Management's IRTC Position: Q4 2025 in Review

Bayesian Capital Management sold out of iRhythm Holdings (IRTC) in Q4 2025, closing a stake of 4,386 shares — an estimated $754K sold.

Bayesian Capital Management first reported a position in IRTC in Q3 2017 and held it in 8 quarters. The position peaked at $1.12M in Q3 2018. 333 funds tracked by Wall St. Rank hold IRTC as of Q4 2025.

  • Bayesian Capital Management reported no remaining iRhythm Holdings position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 4,386 iRhythm Holdings shares in Q4 2025, an estimated $754K.
  • Bayesian Capital Management first reported a position in iRhythm Holdings in Q3 2017 and held it in 8 quarters.
  • Bayesian Capital Management's iRhythm Holdings position peaked at $1.12M in Q3 2018.
  • 333 funds tracked by Wall St. Rank held iRhythm Holdings as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.